CROWDING AND DELIVERY OF HEALTHCARE IN EMERGENCY DEPARTMENTS: THE EUROPEAN PERSPECTIVE



Engineering chimeric antigen receptor-T cells for cancer treatment

Abstract Intratumor heterogeneity of tumor clones and an immunosuppressive microenvironment in cancer ecosystems contribute to inherent difficulties for tumor treatment.Recently, chimeric antigen receptor (CAR) T-cell therapy has been successfully applied in the treatment of B-cell malignancies, underscoring its great potential in antitumor therapy

read more